Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination topical kit** consisting of **isopropyl alcohol**, **dexamethasone sodium phosphate**, and **povidone-iodine**. - **Isopropyl alcohol** acts as a broad-spectrum topical antiseptic and disinfectant, denaturing proteins and dissolving cell membranes in bacteria, fungi, and some viruses. - **Dexamethasone sodium phosphate** is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory activity. It works by suppressing the migration of polymorphonuclear leukocytes and reversing increased capillary permeability, thereby reducing inflammation. - **Povidone-iodine** is a chemical complex that provides a sustained release of iodine, which disrupts the structure and function of microbial proteins and nucleic acids, resulting in broad-spectrum microbicidal activity. The combination is used mainly for cleansing, disinfecting, and reducing inflammation on the skin or mucosa before or after invasive procedures, surgery, or to treat and prevent localized skin or mucosal infections. No unique brand name formulation was identified for this specific triple combination; it is most commonly found as a procedural kit or compounded in healthcare settings[5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + dexamethasone sodium phosphate + povidone-iodine.